Home/STAAR Surgical/Patrick F. Williams

PF

Patrick F. Williams

Chief Financial Officer

Therapeutic Areas

Ophthalmology Refractive Surgery

STAAR Surgical Pipeline

Drug	Indication	Phase
EVO ICL / EVO+ ICL	Myopia & Myopia with Astigmatism	Commercial
Hyperopic ICL	Hyperopia (Farsightedness)	Commercial (Limited)
Presbyopia-Correcting ICL	Presbyopia	Research & Development

Leadership Team at STAAR Surgical

President and Chief Executive Officer

A. John Barnhart

Chief Operating Officer

Dr. Gary M. Wörtz

Chief Medical Officer

Keith A. Holliday

SVP, General Counsel & Corporate Secretary

View full STAAR Surgical profile